TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.

BACKGROUND: Asthma is characterized by variable airflow obstruction and airway hyperresponsiveness in association with airway inflammation under the influence of T(H)2 cytokines. Eosinophilic bronchitis has similar immunopathology to asthma but without disordered airway physiology. Whether eosinoph...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Brightling, C, Symon, F, Birring, S, Bradding, P, Pavord, I, Wardlaw, A
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2002

Παρόμοια τεκμήρια

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
ανά: Brightling, C, κ.ά.
Έκδοση: (2003)

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
ανά: Berry, M, κ.ά.
Έκδοση: (2004)

Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis.
ανά: Siddiqui, S, κ.ά.
Έκδοση: (2007)

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma.
ανά: Brightling, C, κ.ά.
Έκδοση: (2000)

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma
ανά: Brightling, C, κ.ά.
Έκδοση: (2000)

Eosinophilic bronchitis: clinical features, management and pathogenesis.
ανά: Birring, S, κ.ά.
Έκδοση: (2003)

Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma.
ανά: Brightling, C, κ.ά.
Έκδοση: (1999)

Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis.
ανά: Birring, S, κ.ά.
Έκδοση: (2003)

Eosinophilic bronchitis is an important cause of chronic cough.
ανά: Brightling, C, κ.ά.
Έκδοση: (1999)

Eosinophilic bronchitis - what is it and why is it important?
ανά: Brightling, C, κ.ά.
Έκδοση: (2000)

Mepolizumab in refractory eosinophilic asthma.
ανά: Pavord, I, κ.ά.
Έκδοση: (2010)

Chemokine concentrations and mast cell chemotactic activity in BAL fluid in patients with eosinophilic bronchitis and asthma, and in normal control subjects.
ανά: Woodman, L, κ.ά.
Έκδοση: (2006)

Eosinophilic bronchitis: an important cause of prolonged cough.
ανά: Brightling, C, κ.ά.
Έκδοση: (2000)

Observational study of the natural history of eosinophilic bronchitis.
ανά: Berry, M, κ.ά.
Έκδοση: (2005)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
ανά: Berry, M, κ.ά.
Έκδοση: (2007)

Protracted bacterial bronchitis: bronchial aspirate versus bronchoalveolar lavage findings: a single-centre retrospective study
ανά: Stijn Verhulst, κ.ά.
Έκδοση: (2019-12-01)

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.
ανά: Brightling, C, κ.ά.
Έκδοση: (2000)

IL-13 expression by blood T cells and not eosinophils is increased in asthma compared to non-asthmatic eosinophilic bronchitis
ανά: Mistry Vijay, κ.ά.
Έκδοση: (2009-07-01)

Mast-cell infiltration of airway smooth muscle in asthma.
ανά: Brightling, C, κ.ά.
Έκδοση: (2002)

Non-eosinophilic corticosteroid unresponsive asthma.
ανά: Pavord, I, κ.ά.
Έκδοση: (1999)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
ανά: Haldar, P, κ.ά.
Έκδοση: (2009)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
ανά: Green, R, κ.ά.
Έκδοση: (2002)

Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma.
ανά: Brightling, C, κ.ά.
Έκδοση: (2003)

The significance of eosinophilic airway inflammation in asthma
ανά: Pavord, I, κ.ά.
Έκδοση: (2002)

Eosinophils in asthma and other allergic diseases.
ανά: Wardlaw, A, κ.ά.
Έκδοση: (2000)

A case of cough, lymphocytic bronchoalveolitis and coeliac disease with improvement following a gluten free diet.
ανά: Brightling, C, κ.ά.
Έκδοση: (2002)

Re-challenge with ovalbumin failed to induce bronchial asthma in mice with eosinophilic bronchitis.
ανά: Liyan Chen, κ.ά.
Έκδοση: (2013-01-01)

Cytokine release syndrome after bronchoalveolar lavage
ανά: Margaret Guerriero, κ.ά.
Έκδοση: (2023-10-01)

New insights into the role of the mast cell in asthma.
ανά: Brightling, C, κ.ά.
Έκδοση: (2003)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
ανά: Shrimanker, R, κ.ά.
Έκδοση: (2017)

Eosinophils in asthma and airway hyperresponsiveness.
ανά: Brightling, C, κ.ά.
Έκδοση: (2004)

A Patient with Bronchial Asthma in Whom Eosinophilic Bronchitis and Bronchiolitis Developed during Treatment
ανά: Yasutsugu Fukushima, κ.ά.
Έκδοση: (2010-01-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
ανά: Shrimanker, R, κ.ά.
Έκδοση: (2017)

Increased sputum and bronchial biopsy IL-13 expression in severe asthma.
ανά: Saha, S, κ.ά.
Έκδοση: (2008)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
ανά: Haldar, P, κ.ά.
Έκδοση: (2014)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
ανά: Bilocca, D, κ.ά.
Έκδοση: (2017)

Objective quantitative analysis of eosinophils and bronchial epithelial cells in induced sputum by laser scanning cytometry.
ανά: Woltmann, G, κ.ά.
Έκδοση: (1999)

Chapter 11. Mast cell localization within the airway smooth muscle: Relationship to airway hyperresponsiveness and other asthma phenotypes
ανά: Wardlaw, A, κ.ά.
Έκδοση: (2004)

The identification of eosinophilic gastroenteritis in prednisone-dependent eosinophilic bronchitis and asthma
ανά: Nair Parameswaran, κ.ά.
Έκδοση: (2011-03-01)

Association between lymphocyte count in bronchoalveolar lavage fluid and mortality
ανά: Yifu Si, κ.ά.
Έκδοση: (2021-09-01)